Literature DB >> 6277652

Loss of rat cerebral cortical opiate receptors following chronic desimipramine treatment.

T Reisine, P Soubrie.   

Abstract

The characteristics of central opiate and beta-adrenergic receptors were studied after giving the tricyclic antidepressant desimipramine (DMI) to rats. Administration of DMI for 1 or 7 days did not alter cortical opiate or beta-adrenergic receptors. However, after 21 days of treatment there was a significant subsensitivity of both these receptors in the cortex. A specific loss of receptor sites for opiate binding was detected with no change in affinity. After a similar time of treatment, opiate receptors in the corpus striatum and hippocampus were the same as the controls. The data suggest that change in cortical opiate receptors may be important in the mechanism of action of antidepressants.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6277652     DOI: 10.1016/0014-2999(82)90532-5

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

1.  Interaction of opioids with antidepressant-induced antinociception.

Authors:  F Sierralta; G Pinardi; M Mendez; H F Miranda
Journal:  Psychopharmacology (Berl)       Date:  1995-12       Impact factor: 4.530

2.  Chronic antidepressant counteracts the conditioned analgesia induced by a context previously associated with inescapable shock.

Authors:  V S Murua; V A Molina
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

3.  Prophylactic treatment with the tricyclic antidepressant desipramine prevents development of paclitaxel-induced neuropathic pain through activation of endogenous analgesic systems.

Authors:  Liting Deng; Wan-Hung Lee; Zhili Xu; Alexandros Makriyannis; Andrea G Hohmann
Journal:  Pharmacol Res       Date:  2016-10-20       Impact factor: 7.658

4.  Influence of naloxone on antidepressant drug effects in the forced swimming test in mice.

Authors:  J L Devoize; F Rigal; A Eschalier; J F Trolese; M Renoux
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

5.  Effect of the antidepressant nefazodone on the density of cells expressing mu-opioid receptors in discrete brain areas processing sensory and affective dimensions of pain.

Authors:  Antonio Ortega-Alvaro; Ignacio Acebes; Gonzalo Saracíbar; Enrique Echevarría; Luis Casis; Juan Antonio Micó
Journal:  Psychopharmacology (Berl)       Date:  2004-04-27       Impact factor: 4.530

6.  Inhibition of presynaptic alpha-2-adrenoceptor and opioid receptor agonist responses in the rat vas deferens by chronic imipramine treatment.

Authors:  R A Keith; A I Salama
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-04       Impact factor: 3.000

7.  Study of the clomipramine-morphine interaction in the forced swimming test in mice.

Authors:  A Eschalier; J Fialip; O Varoquaux; M C Makambila
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

Review 8.  Rhythm and blues. Neurochemical, neuropharmacological and neuropsychological implications of a hypothesis of circadian rhythm dysfunction in the affective disorders.

Authors:  D Healy
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.